Arteris' (AIP) Sell (D-) Rating Reaffirmed at Weiss Ratings

Key Points

• Weiss Ratings has reaffirmed a sell (D-) rating for Arteris (NASDAQ:AIP), indicating continued concerns about its stock performance.
• Despite the negative rating from Weiss, other analysts have provided a more optimistic outlook, with TD Cowen upgrading Arteris to a buy rating and raising the target price from $12.00 to $15.00.
• Arteris recently reported earnings of ($0.11) per share, with revenues slightly exceeding expectations at $16.50 million for the quarter.

Arteris (NASDAQ:AIP - Get Free Report)'s stock had its "sell (d-)" rating reissued by Weiss Ratings in a research report issued on Wednesday,Weiss Ratings reports.

Other equities research analysts have also issued reports about the company. TD Cowen raised their target price on Arteris from $12.00 to $15.00 and gave the company a "buy" rating in a research report on Wednesday, August 6th. Wall Street Zen raised Arteris from a "sell" rating to a "hold" rating in a report on Monday, September 15th. Three research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $15.00.

Arteris Stock Performance

Shares of Arteris stock traded up $0.54 on Wednesday, reaching $13.49. 816,022 shares of the company's stock were exchanged, compared to its average volume of 570,716. The company has a market capitalization of $575.35 million, a P/E ratio of -16.45 and a beta of 1.45. Arteris has a 52 week low of $5.46 and a 52 week high of $14.58. The firm's 50-day moving average is $9.78 and its two-hundred day moving average is $8.50.

Arteris (NASDAQ:AIP - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.11). Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%.The company had revenue of $16.50 million for the quarter, compared to analysts' expectations of $16.35 million. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, analysts expect that Arteris will post -0.73 EPS for the current fiscal year.

Insider Transactions at Arteris

In related news, CFO Nicholas B. Hawkins sold 3,887 shares of the company's stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $10.92, for a total transaction of $42,446.04. Following the completion of the transaction, the chief financial officer owned 100,011 shares in the company, valued at $1,092,120.12. This represents a 3.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO K Charles Janac sold 11,821 shares of the company's stock in a transaction that occurred on Friday, October 3rd. The shares were sold at an average price of $11.07, for a total value of $130,858.47. Following the transaction, the chief executive officer owned 167,514 shares of the company's stock, valued at approximately $1,854,379.98. This represents a 6.59% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 499,760 shares of company stock worth $6,008,129. 33.70% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Arteris

Institutional investors have recently modified their holdings of the stock. Raymond James Financial Inc. purchased a new stake in shares of Arteris in the second quarter worth $32,000. CWM LLC grew its stake in shares of Arteris by 4,810.1% in the first quarter. CWM LLC now owns 10,213 shares of the company's stock worth $71,000 after acquiring an additional 10,005 shares during the last quarter. Cambridge Investment Research Advisors Inc. purchased a new stake in shares of Arteris in the first quarter worth $95,000. Savant Capital LLC purchased a new stake in shares of Arteris in the second quarter worth $97,000. Finally, Kapitalo Investimentos Ltda purchased a new stake in shares of Arteris in the second quarter worth $104,000. 64.36% of the stock is owned by hedge funds and other institutional investors.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.